Related Experiment Video
Updated: May 29, 2026
06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
[Trophoblastic diseases: a multidisciplinary approach, a first Swiss center]
A-L Rougemont1, M-F Pelte, F Sloan Béna
1Service de pathologie clinique, Département de médecine génétique et de laboratoire, HUG, Genève. Anne-Laure.Rougemont@hcuge.ch
Revue Medicale Suisse
|September 9, 2011
Summary
This study introduces a specialized center for rare trophoblastic diseases, offering integrated diagnosis and treatment recommendations. The multidisciplinary approach ensures optimal patient care and surveillance for these complex conditions.
Area of Science:
- Gynecology
- Oncology
- Pathology
- Genetics
Context:
- Trophoblastic diseases are rare and complex, requiring specialized management.
- The first Center for Trophoblastic Diseases in Switzerland was established in Geneva in 2009.
- This center formalizes collaboration among obstetricians-gynecologists, pathologists, geneticists, radiologists, and oncologists.
Purpose:
- To establish a centralized, multidisciplinary approach for the diagnosis and treatment of trophoblastic diseases.
- To provide integrative diagnostic services including histological review, p57KIP2 immunohistochemistry, and QF-PCR for ploidy analysis.
- To offer evidence-based treatment and beta-hCG monitoring recommendations to referring physicians.
Summary:
- An integrative diagnosis is proposed, involving centralized review of histological slides, anti-p57KIP2 immunohistochemistry, and Quantitative fluorescent polymerase chain reaction (QF-PCR) for ploidy analysis.
- The referring physician receives tailored treatment and beta-hCG dosage recommendations.
- This collaborative model ensures comprehensive patient management.
Impact:
- Facilitates optimal surveillance and treatment for patients with trophoblastic diseases.
- Enhances diagnostic accuracy through a pluridisciplinary review process.
- Serves as a model for specialized care in rare gynecological and oncological conditions.
